Nanoparticle-aptamer bioconjugates for cancer targeting

Expert Opinion on Drug Delivery
Omid C FarokhzadRobert Langer

Abstract

The combination of targeted drug delivery and controlled-release technology may pave the road for more effective yet safer chemotherapeutic options for cancer therapy. Drug-encapsulated polymeric nanoparticle-aptamer bioconjugates represent an emerging technology that can facilitate the delivery of chemotherapeutics to primary and metastatic tumours. Aptamers are short nucleic acid molecules with binding properties and biochemical characteristics that may make them suitable for use as targeting molecules. The goal of this review is to summarise the key components that are required for creating effective cancer targeting nanoparticle-aptamer bioconjugates. The field of controlled release and the structure and properties of aptamers, as well as the criteria for constructing effective conjugates, will be discussed.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Jan 1, 1991·Microvascular Research·L T Baxter, R K Jain
Mar 11, 1994·Science·R D JenisonB Polisky
Oct 27, 1995·The Journal of Biological Chemistry·L BeigelmanP Haeberli
Apr 1, 1995·Journal of Pharmaceutical Sciences·D BazileM Veillard
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S GibaudP Couvreur
Apr 1, 1994·Analytical Biochemistry·D Sehgal, I K Vijay
Mar 18, 1994·Science·R GrefR Langer
Jan 1, 1996·Methods in Enzymology·T Fitzwater, B Polisky
Jan 1, 1996·Molecular Biology Reports·J S DengJ K Hofmeister
Apr 1, 1997·Pharmaceutical Research·M DemoyP Couvreur
Jun 20, 1997·Science·D A EdwardsR Langer
Mar 31, 1998·Journal of Pharmaceutical Sciences·J GaoR Langer
Nov 21, 1998·Analytical Chemistry·I GermanR T Kennedy
Feb 13, 1999·Nature·J T SantiniR Langer
Oct 16, 1999·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·T Haak
Feb 5, 2000·Science·T Hermann, D J Patel
Feb 12, 2000·Journal of Microencapsulation·P SommerfeldU Schroeder
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Jun 29, 2000·Annual Review of Biochemistry·D S Wilson, J W Szostak
Oct 18, 2000·The Journal of Clinical Investigation·B J Hicke, A W Stephens
Oct 18, 2000·The Journal of Clinical Investigation·R R WhiteC P Rusconi
Feb 17, 2001·Biochemical and Biophysical Research Communications·S JeongJ Yu
Jul 7, 2001·Science·R Langer
Oct 9, 2001·The Journal of Biological Chemistry·B J HickeS Warren
Jan 10, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J ElisseeffR Langer
Mar 19, 2002·International Journal of Pharmaceutics·Jasmine Davda, Vinod Labhasetwar
Mar 21, 2002·Nature Reviews. Cancer·Ralph Weissleder
Sep 3, 2002·Advanced Drug Delivery Reviews·Irène BriggerPatrick Couvreur
Oct 22, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael ChornyGershon Golomb
Feb 1, 2003·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Naonobu TakahiraKouji Naruse

❮ Previous
Next ❯

Citations

Apr 9, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Partha RayRebecca Smock Woodruff
Aug 10, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Giovanni Lucignani
Oct 1, 2008·Histochemistry and Cell Biology·Paul Debbage, Werner Jaschke
Jul 30, 2008·Biomedical Microdevices·Takemi TanakaMauro Ferrari
Dec 18, 2013·International Journal of Pharmaceutics·Anagha BhakayRajesh Dave
Aug 20, 2011·Accounts of Chemical Research·Heebeom KooIck Chan Kwon
Aug 13, 2008·Nanomedicine·Bi-Botti Celestin Youan
Mar 28, 2009·International Journal of Molecular Sciences·Ke-Tai GuoHans P Wendel
Aug 15, 2014·Molecular Therapy. Nucleic Acids·Zihua ZengYouli Zu
Apr 15, 2011·Journal of Drug Delivery·Manish ShankerRajagopal Ramesh
Mar 31, 2009·Expert Opinion on Drug Delivery·Manasi DasSanjeeb K Sahoo
Mar 6, 2010·Expert Opinion on Drug Delivery·Ron B ShmueliJordan J Green
Feb 16, 2008·Journal of Drug Targeting·Suphiya Parveen, Sanjeeb K Sahoo
Aug 9, 2007·Expert Opinion on Drug Delivery·Jason SakamotoMauro Ferrari
Aug 30, 2008·Expert Opinion on Drug Delivery·Omid C Farokhzad
Aug 10, 2012·Journal of Drug Targeting·Shaheen SultanaMohammed Ali
Nov 26, 2014·Expert Opinion on Drug Delivery·Alejandro BaezaMaría Vallet-Regí
Sep 13, 2013·Journal of Drug Targeting·Shardool JainMansoor M Amiji
Sep 1, 2007·Expert Opinion on Drug Discovery·Aniela WochnerMartina Rimmele
Nov 1, 2010·Expert Opinion on Medical Diagnostics·Sonia Da Rocha GomesJean-Jacques Toulmé
Dec 15, 2015·ChemMedChem·Pradeepkumar L PatelDavid Sabatino
Aug 2, 2012·Pharmacology & Therapeutics·Domenica Musumeci, Daniela Montesarchio
Aug 16, 2011·International Journal of Pharmaceutics·Thomas PerrierJean-Pierre Benoît
Jan 10, 2016·Nuclear Medicine and Biology·Marlies GijsAndré Luxen
Mar 10, 2009·European Journal of Radiology·Dipanjan PanShelton D Caruthers
Oct 9, 2008·Advanced Drug Delivery Reviews·James D ByrneLisa Brannon-Peppas
May 3, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huaiwen ChenYanqiang Zhong
Feb 12, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Srinivas GantaMansoor Amiji
Jan 15, 2008·Urologic Oncology·Frank AlexisOmid C Farokhzad
Oct 16, 2007·Biomaterials·Paolo Decuzzi, Mauro Ferrari
Nov 6, 2007·Current Opinion in Biotechnology·Jeffrey M Karp, Robert Langer
Apr 26, 2016·Molecular Therapy. Nucleic Acids·Margherita IaboniGerolama Condorelli
Sep 1, 2015·International Journal of Pharmaceutics·Behrang Shiri VarnamkhastiRassoul Dinarvand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.